Glucose Tolerance
92/100
This product looks safe
- Niacin: 50mg is 1.4× the Tolerable Upper Intake Level (35mg)
- 60% of ingredients have research evidence
C
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
⚠️ Niacin: 50mg is 1.4× the Tolerable Upper Intake Level (35mg)
Label Data
1 Capsule(s)
Serving Size
90
Servings
Other Combinations
Product Type
60%
Evidence Coverage
Supplement Facts — Evidence Check
50 mg
(250% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 1.4× (UL: 35 mg)
📚 193 studies (Tier A: 5, B: 63)
20 mg
(1000% DV)
📊 15.4× RDA — above typical dose (UL: 100 mg)
📚 113 studies (Tier A: 3, B: 35)
250 mcg
(208% DV)
📊 7.1× RDA — above typical dose
📚 197 studies (Tier A: 1, B: 55)
L-Glutathione
2.5 mg
Guar Gum
450 mg
Other Ingredients
Hydroxypropyl Methylcellulose
Microcrystalline Cellulose
Silicon Dioxide
Magnesium Stearate
Label Claims — Verification
❓
All Other
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Adult (18 - 50 Years)
No Allergies
Product Information
📋 Directions for Use
Suggested Use As a dietary supplement, 1 capsule daily with a meal and 8 ounces of water, or as directed by a healthcare practitioner.
Additional Information
Variations in product color may occur.
Keep in a cool, dry place, tightly capped.
Rev. 004
Product Details
UPC / SKU
7 13947 71900 2
DSLD Entry Date
2015-12-23
Product Type
Other Combinations
Form
Capsule
Brand
Allergy Research Group
DSLD ID
54485
Data Updated
2026-04-11
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Serotone 5HTP 50 mg
Higher Nature
100
Serotone 5HTP 100 mg
Higher Nature
100
ChromeMate
NOW
100
ChromeMate 200 mcg
Protocol For Life Balance
100
Non Flush Niacin
Highland Laboratories
100